Published in Drug Law Weekly, November 15th, 2005
"Several key market events are expected to shape the pharmaceutical industry in 2006," said Murray Aitken, senior vice president, Corporate Strategy, IMS Health. "These include the introduction of the Medicare drug benefit in the U.S., expected patent loss and generic introduction for six blockbuster products, and continued efforts by local governments to reduce drug spending and manage patient access to branded pharmaceuticals. While some pharmaceutical...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.